Future Science Group
Supplementary Table 2.docx (21.63 kB)

imt-2021-0013 - Supplementary Material - Ruxolitinib, a JAK1/JAK2 selective inhibitor, ameliorates acute and chronic steroid-refractory GvHD mouse models

Download (21.63 kB)
posted on 2021-09-08, 10:52 authored by Figshare Future Science GroupFigshare Future Science Group, Eduardo Huarte, Michael Peel, Ashish Juvekar, Philip Dubé, Sarala Sarah, Lynn Stephens, Becky Stewart, Brian Long, Philip Czerniak, Julian Oliver, Paul Smith
Supplementary Table 2. Assessment of GvHD in transplanted mice – modified chronic sclerodermatous GvHD scoring protocol.


Incyte Corporation